NYSEAMERICAN:ISR - IsoRay Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$0.48 +0.01 (+2.13 %)
(As of 06/21/2018 12:08 PM ET)
Previous Close$0.48
Today's Range$0.48 - $0.48
52-Week Range$0.36 - $0.64
Volume400 shs
Average Volume196,047 shs
Market Capitalization$24.87 million
P/E RatioN/A
Dividend YieldN/A
Beta1.22
IsoRay logoIsoRay, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma. It sells its products to facilities or physician practices that utilize multiple surgical facilities at which primarily prostate brachytherapy procedures are performed. The company was formerly known as Century Park Pictures Corporation and changed its name to IsoRay, Inc. in 2005. IsoRay, Inc. was founded in 1983 and is based in Richland, Washington.

Receive ISR News and Ratings via Email

Sign-up to receive the latest news and ratings for ISR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
SymbolNYSEAMERICAN:ISR
CUSIPN/A
Phone+1-509-3751202

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-95.25%
Return on Equity-69.11%
Return on Assets-58.22%

Miscellaneous

EmployeesN/A
Outstanding Shares55,100,000

IsoRay (NYSEAMERICAN:ISR) Frequently Asked Questions

What is IsoRay's stock symbol?

IsoRay trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ISR."

How were IsoRay's earnings last quarter?

IsoRay, Inc. (NYSEAMERICAN:ISR) announced its quarterly earnings results on Thursday, May, 3rd. The healthcare company reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.03) by $0.01. The healthcare company had revenue of $1.57 million for the quarter. IsoRay had a negative net margin of 95.25% and a negative return on equity of 69.11%. View IsoRay's Earnings History.

What price target have analysts set for ISR?

2 equities research analysts have issued twelve-month price targets for IsoRay's stock. Their forecasts range from $1.00 to $2.00. On average, they anticipate IsoRay's share price to reach $1.50 in the next year. View Analyst Ratings for IsoRay.

Are investors shorting IsoRay?

IsoRay saw a decline in short interest in the month of May. As of May 31st, there was short interest totalling 100,258 shares, a decline of 35.2% from the May 15th total of 154,774 shares. Based on an average trading volume of 361,924 shares, the short-interest ratio is currently 0.3 days. Currently, 0.2% of the shares of the company are short sold. View IsoRay's Current Options Chain.

Who are some of IsoRay's key competitors?

Who are IsoRay's key executives?

IsoRay's management team includes the folowing people:
  • Mr. Thomas C. LaVoy CPA, Chairman & CEO (Age 58)
  • Mr. William Cavanagh III, COO & Chief Scientific Officer (Age 52)
  • Mr. Michael L. Krachon, VP of Sales & Marketing (Age 47)
  • Mr. Mark Austin CPA, Principal Accounting & Financial Officer and Controller (Age 31)
  • Mrs. Jennifer Streeter, VP of HR (Age 48)

Has IsoRay been receiving favorable news coverage?

News articles about ISR stock have been trending somewhat positive this week, according to Accern Sentiment. Accern identifies negative and positive press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. IsoRay earned a daily sentiment score of 0.10 on Accern's scale. They also gave media headlines about the healthcare company an impact score of 47.05 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

How do I buy shares of IsoRay?

Shares of ISR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is IsoRay's stock price today?

One share of ISR stock can currently be purchased for approximately $0.48.

How big of a company is IsoRay?

IsoRay has a market capitalization of $24.87 million.

How can I contact IsoRay?

IsoRay's mailing address is 350 Hills St Ste 106, RICHLAND, WA 99354-5511, United States. The healthcare company can be reached via phone at +1-509-3751202.


MarketBeat Community Rating for IsoRay (ISR)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  83 (Vote Outperform)
Underperform Votes:  48 (Vote Underperform)
Total Votes:  131
MarketBeat's community ratings are surveys of what our community members think about IsoRay and other stocks. Vote "Outperform" if you believe ISR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ISR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.